In this article Medilink Midlands' Head of Connectivity Chris Dyke shares his thoughts on the Implementation of the Future Regulations. In viewing this new document (9 Jan 2024) the first part of Implementation of the Future Regulations provides additional clarity to what has been previously announced i.e. ‘Transitional Arrangements’ and...
Patron Spotlight: Health Innovation East Midlands
Medilink Midlands offers Patronage to prominent organisations within the Midlands that recognise and demonstrate the importance of life sciences to the region, and that appreciate the positive contribution that Medilink makes to the sector through our diverse programme of events and business support activities. Health Innovation East Midlands (formerly East...
Medilink Midlands awarded Investors in People accreditation
Medilink Midlands has been awarded the ‘We invest in people’ standard accreditation by Investors in People, the UK’s leading people management business improvement standard. The accolade means principles and practices around supporting people are in place at Medilink Midlands and everyone understands how to use them to make work better....
Happy New Year and a warm welcome to 2024 from everybody at Medilink Midlands.
We hope you all had an enjoyable time over the holidays and, like us, are keen to see what 2024 has in store. To kick off the year, we wanted to highlight a few dates for your diaries. Firstly, we’re hosting our Annual Business Awards at the Athena, Leicester this...
Registrations open for Venturefest WM 2024
Registration for Venturefest West Midlands 2024 is now open for entrepreneurs and innovators to develop their businesses and meet potential investors. The West Midlands Combined Authority (WMCA) is sponsoring and co-hosting this free event, which offers the opportunity for entrepreneurs, innovators and investors to share ideas for co-operation and collaboration,...
MHRA supports launch of Innovate UK’s first-of-its-kind initiative to fund new Regulatory Science and Innovation Networks
Applications are now open for academic institutions wishing to bid for funding to collaborate with others to establish new Regulatory Science and Innovation Networks (RSINs) in innovative sectors. Launched on Wednesday 13 December by Innovate UK, the Medicines and Healthcare products Regulatory Agency (MHRA) has joined partners across government including...
What defines guidelines for R&D tax purposes?
Within R&D tax credit frameworks, there exist varying degrees of guidance, each with distinct purposes. Firstly, there’s the ‘Meaning of Research & Development for Tax Purposes: guidelines’ which goes beyond mere suggestions. It’s the legal foundation embedded in Section 1006 of the Income Tax Act 2007. These guidelines constitute the backbone...
The Impact of the Additional Information Form on R&D Tax Relief Claims 4 Months In
Unveiling the Unseen: The Impact of the Additional Information Form on R&D Tax Relief Claims 4 Months In In the dynamic landscape of R&D tax relief schemes, a pivotal change has quietly disrupted the routine of many R&D claim providers—the introduction of the Additional Information Form (AIF). Shockingly, over half...
Comprehensive Insights into the Combined R&D Tax Relief Schemes
Navigating the Impending Merger: Comprehensive Insights into the Combined R&D Tax Relief Schemes The recent Autumn Statement officially announced the merger of the R&D tax relief schemes, scheduled to take effect from 1st April 2024, for accounting periods starting after this date. This significant reform, following a consultation opened in January...
5 key considerations in connected device development
The value of a well-managed connected device can be significant, to both individuals and businesses. So, it is no surprise that the connected device ecosystem is not only thriving but growing exponentially. In fact, McKinsey global institute is estimating that connected (IoT) products and services will generate between $5.5 trillion...
